Molecular hypometabolism is a state of metabolic dysfunction characterized by: (1) ribosomal dysfunction—mycotoxins damage the sarcin-ricin loop (nucleotide position 1.15) on rRNA, preventing one adenosine replacement, disabling ~50% of ribosomal protein-making capacity; (2) mitochondrial dysfunction—pyruvate fails to enter mitochondria for ATP production and instead gets converted to lactic acid (Warburg effect), causing lactic acidosis in 85% of CIRS patients; (3) this leads to cellular energy rationing and underperformance across all systems.